TITLE

MAKING KNOWLEDGE AND MAKING DRUGS? EXPERIMENTING WITH UNIVERSITY INNOVATION CAPACITY

AUTHOR(S)
Vertinsky, Liza
PUB. DATE
March 2013
SOURCE
Emory Law Journal;2013, Vol. 62 Issue 4, p741
SOURCE TYPE
Academic Journal
DOC. TYPE
Article
ABSTRACT
No abstract available.
ACCESSION #
89013516

 

Related Articles

  • Digital bites.  // Pharmaceutical Technology Europe;Sep2010, Vol. 22 Issue 9, p40 

    The article highlights several clippings concerning contract services industry from the Web site www.pharmtech.com. It says that the outsourcing of early drug development can be regarded as strategic or tactical. It suggests that contract manufacturing organisations (CMOs) must consider their...

  • Restore the US Lead in Biomedical Research. Dzau, Victor J.; Fineberg, Harvey V. // JAMA: Journal of the American Medical Association;1/13/2015, Vol. 313 Issue 2, p143 

    The author discusses ways to restore the progress of the U.S. in biomedical research. Topics discussed include an article within the issue about other countries' efforts to outpace the U.S., decrease in U.S. medical research spending between 2004 and 2012, and need for strategic partnerships...

  • The determinants of pharmaceutical research and development expenditures. Grabowski, Henry; Vernon, John // Journal of Evolutionary Economics;2000, Vol. 10 Issue 1/2, p201 

    Abstract. Since the late 1970s, pharmaceutical R&D has grown at a rapid rate relative to sales and other variables. In this paper, we examine the determinants of pharmaceutical R&D using a pooled data sample of 11 major drug firms over the period 1974 to 1994. We find that expected returns and...

  • Prescription marketing. Tyndale-Biscoe, Julian // Marketing (00253650);8/7/2003, p20 

    Trying to reach consumers is a hard task for drug companies in Great Britain. Pharmaceutical companies are not only facing increased competition and regulatory hurdles, but also a drop in research and development and downward price pressure. Research and development is one key battlefield....

  • Emerging role of pharmacoeconomics in the research and development decision-making process. Dimasi, J.A.; Caglarcan, E.; Wood-Armany, M. // PharmacoEconomics;Jul2001, Vol. 19 Issue 7, p753 

    Objectives: This study examines the organisational structure of pharmacoeconomics departments in major pharmaceutical and biotechnology companies, the impediments to optimal use of pharmacoeconomic evaluations by companies and the integration of pharmacoeconomic analysis with...

  • WEEK IN WASHINGTON.  // BioWorld Insight;8/12/2013, Vol. 21 Issue 33, p6 

    The article reports that the approval of the legislative bill H.R. 2985 on combination drugs by the U.S. House of Representatives can positively impact the U.S. drug makers and pharmaceutical firms and mentions that the bill can offer easy approval for manufacturing combination drugs.

  • In Flux. Netterwald, James // Drug Discovery & Development;Nov2008, Vol. 11 Issue 11, p26 

    The article discusses the emergence of pharmacogenetic approach to the pharmaceutical industry in the U.S. Pharmacogenetic, which deals with drug targets on the DNA level in the form of one or a few genes, rules the research and development (R&D) landscape in some drug companies. It highlights...

  • DSIN, Ranbaxy & RSC meet on "Overcoming the Bottlenecks in Drug Discovery and Development".  // Chemical Business;Apr2014, Vol. 28 Issue 4, p57 

    The article discusses the highlights of the symposium "Overcoming the Bottlenecks in Drug Discovery and Development" held in Gurgaon, India on March 20 & 21, 2014. Lectures from leading researchers centered on four key pharmaceutical research and development (R&D) themes, such as biological hit...

  • On the Future of Drug Discovery. Campbell, Simon // Chemistry International;Sep/Oct2012, Vol. 34 Issue 5, p10 

    The article discusses the challenges facing the pharmaceutical industry due to revenue losses from lost patent protection. It is said that the industry has gone through reductions in research and development budgets, closure of research sites, and head count losses. It highlights the need for a...

Share

Read the Article

Courtesy of THE LIBRARY OF VIRGINIA

Sorry, but this item is not currently available from your library.

Try another library?
Sign out of this library

Other Topics